EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Production of Bioactive Porcine Lactoferrin through a Novel Glucose-Inducible Expression System in Pichia pastoris: Unveiling Antimicrobial and Anticancer Functionalities

Chih-Ching Yen iD, Pei-Ying Wu, Huan Ou-Yang iD, Hsiao-Ling Chen, Kowit-Yu Chong iD, Ro-Lin Chang iD, Chuan-Mu Chen iD

International Journal of Molecular Sciences · 02.02.2024 · 25 (3) · 1818

DOI: 10.3390/ijms25031818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.02.2024. Verfasst von Chih-Ching Yen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, China Medical University Hospital, College of Health Care, China Medical University, Taichung 404, Taiwan. Hauptthemen laut MEDLINE: Anti-Infective Agents, Lactoferrin, Recombinant Proteins. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Taiwan, Ministry of Education, Taiwan, Ministry of Science and Technology of Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lactoferrin (LF) stands as one of the extensively investigated iron-binding glycoproteins within milk, exhibiting diverse biological functionalities. The global demand for LF has experienced consistent growth. Biotechnological strategies aimed at enhancing LF productivity through microbial expression systems offer substantial cost-effective advantages and exhibit fewer constraints compared to traditional animal bioreactor technologies. This study devised a novel recombinant plasmid, wherein the AOX1 promoter was replaced with a glucose-inducible G1 promoter (PG1) to govern the expression of recombinant porcine LF (rpLF) in Pichia pastoris GS115. High-copy-number PG1-rpLF yeast clones were meticulously selected, and subsequent induction with 0.05 g/L glucose demonstrated robust secretion of rpLF. Scaling up production transpired in a 5 L fermenter, yielding an estimated rpLF productivity of approximately 2.8 g/L by the conclusion of glycerol-fed fermentation. A three-step purification process involving tangential-flow ultrafiltration yielded approximately 6.55 g of rpLF crude (approximately 85% purity). Notably, exceptional purity of rpLF was achieved through sequential heparin and size-exclusion column purification. Comparatively, the present glucose-inducible system outperformed our previous methanol-induced system, which yielded a level of 87 mg/L of extracellular rpLF secretion. Furthermore, yeast-produced rpLF demonstrated affinity for ferric ions (Fe3+) and exhibited growth inhibition against various pathogenic microbes (E. coli, S. aureus, and C. albicans) and human cancer cells (A549, MDA-MB-231, and Hep3B), similar to commercial bovine LF (bLF). Intriguingly, the hydrolysate of rpLF (rpLFH) manifested heightened antimicrobial and anticancer effects compared to its intact form. In conclusion, this study presents an efficient glucose-inducible yeast expression system for large-scale production and purification of active rpLF protein with the potential for veterinary or medical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Infective AgentsLactoferrinRecombinant ProteinsAnimalsCattleHumansEscherichia coliFermentationGlucosePichiaSaccharomycetalesStaphylococcus aureusSwine

Stichwörter der Autor:innen

G1 promoterPichia pastorisanticancerantimicrobialfermentationiron-bindinglactoferrintangential-flow ultrafiltration

Substanzen

Anti-Infective AgentsGlucoseLactoferrinRecombinant Proteins

Autor:innen und Institutionen

  • Department of Internal Medicine, China Medical University Hospital, College of Health Care, China Medical University, Taichung 404, Taiwan.
  • Department of Life Sciences, Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan.
  • Department of Biomedical Science, Da-Yeh University, Changhua 515, Taiwan.
  • Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
  • Hyperbaric Oxygen Medical Research Laboratory, Bone and Joint Research Center, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan.
  • The iEGG and Animal Biotechnology Center, Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan.

ORCID-Profile: Chih-Ching Yen, Huan Ou-Yang, Kowit-Yu Chong, Ro-Lin Chang, Chuan-Mu Chen

Förderung

  • Ministry of Science and Technology, Taiwan
  • Ministry of Education, Taiwan
  • Ministry of Science and Technology of Taiwan
  • Ministry of Education

Zitieren

APA

Yen, C. C., Wu, P. Y., Ou-Yang, H., Chen, H. L., Chong, K. Y., Chang, R. L., & Chen, C. M. (2024). Production of Bioactive Porcine Lactoferrin through a Novel Glucose-Inducible Expression System in Pichia pastoris: Unveiling Antimicrobial and Anticancer Functionalities. International Journal of Molecular Sciences, 25(3), 1818. https://doi.org/10.3390/ijms25031818

Vancouver

Yen CC, Wu PY, Ou-Yang H, Chen HL, Chong KY, Chang RL, et al. Production of Bioactive Porcine Lactoferrin through a Novel Glucose-Inducible Expression System in Pichia pastoris: Unveiling Antimicrobial and Anticancer Functionalities. International Journal of Molecular Sciences. 2024;25(3):1818. doi:10.3390/ijms25031818

BibTeX
@article{Yen2024,
  author = {Yen, Chih-Ching and Wu, Pei-Ying and Ou-Yang, Huan and Chen, Hsiao-Ling and Chong, Kowit-Yu and Chang, Ro-Lin and Chen, Chuan-Mu},
  title = {Production of Bioactive Porcine Lactoferrin through a Novel Glucose-Inducible Expression System in Pichia pastoris: Unveiling Antimicrobial and Anticancer Functionalities},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {3},
  pages = {1818},
  doi = {10.3390/ijms25031818}
}
Kostenlos starten →